The effect of tranexamic acid on reduction of edema and ecchymosis

Investigation the effect of tranexamic acid on reduction of edema and ecchymosis in patients undergoing rhinoplasty

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200112046095N1

Enrollment

120

Registered

2020-05-30

Start date

2020-03-20

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty. Encounter for procedures for purposes other than remedying health state

Interventions

Intervention 1: Intervention group: Receiving 1000 mg tranexamic acid 2 hours before operation and 1000 mg every 8 hours after operation for 3 times. Intervention 2: Control group: Receiving tranexami

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients candidate for rhinoplasty

Exclusion criteria

Exclusion criteria: Allergy to tranexamic acid Having coagulation disorders Having a history of gastric ulcer or bleeding

Design outcomes

Primary

Measure	Time frame
Edema. Timepoint: On post-operative days 3, 5, 7 and 10. Method of measurement: 0-4 Point scoring tool.;Ecchymosis. Timepoint: On post-operative days 3, 5, 7 and 10. Method of measurement: 0-4 Point scoring tool.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHanie Samareh khammar

Zahedan University of Medical Sciences

hani.samareh@zaums.ac.ir+98 54 3348 9551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026